Rory B. Riggs - 26 May 2021 Form 4 Insider Report for FIBROGEN INC (FGEN)

Role
Director
Signature
/s/ Dorothy Pacini, Attorney-in-fact
Issuer symbol
FGEN
Transactions as of
26 May 2021
Net transactions value
$0
Form type
4
Filing time
28 May 2021, 19:08:40 UTC
Previous filing
11 May 2021
Next filing
04 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FGEN Common Stock Award $0 +4,700 +1.2% $0.000000 395,750 26 May 2021 Direct F1
holding FGEN Common Stock 605,713 26 May 2021 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FGEN Stock Option (Right to Buy) Award $0 +7,800 $0.000000 7,800 26 May 2021 Common Stock 7,800 $20.86 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the grant of restricted stock units that vest on the earlier of May 26, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date.
F2 Shares are held by New Ventures I, LLC. The reporting person is Managing Member of New Ventures I, LLC and has voting and investment control with respect to the shares held by New Ventures I, LLC.
F3 Options vest on the earlier of May 26, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date.